Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1
Clinical trial NCT01717638 · COMPLETED
Trial details
- NCT number
- NCT01717638
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 805
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.